A NEW Covid drug that will help the most vulnerable patients is available on the NHS from today.
The drug Sotrovimab will be given by injection and doctors say it has an ‘important role’ in the fight against Covid-19.
Starting today, it will be given to patients most at risk of severe coronavirus infection to help fight the illness, along with other interventions such as booster injections.
This will include cancer patients, transplant recipients and other high-risk groups in society.
The drug works best when given to people when the initial symptoms of Covid-19 start and is thought to protect them from getting very sick or dying from the disease.
It is thought that when identifying symptoms, specialists will consider a new persistent cough, high temperature, and loss of taste and smell.
Despite reports that Omicron’s symptoms differ from those highlighted by the NHS, experts say early trials show the drug is still effective in patients with Omicron.
In trials conducted by drug manufacturer Glaxo Smith Kilne (GSK), experts found that it reduced the risk of hospitalization in high-risk patients by 79%.
The Sun is also urging readers to sign up for the Jabs Army campaign so that the rollout goes as smoothly and as quickly as possible.
Boosted shot is the best defense against Omicron, with early data showing it pushing efficiency up to 75%.
🔵 Read ours Covid-19 live blog for latest update
Dr Jenny Harries, UKHSA Chief Executive, said: “Once again, we urge everyone who is likely to receive a boost to come forward and do so. That is the best defense we have against this new highly contagious variant. “
Experts at GSK say more tests are still needed to determine how effective the drug is against Omicron.
It works by binding to the mutated protein on the outside of the virus.
This in turn prevents it from entering human cells.
In this way, it prevents the multiplication of cells inside the human body.
Professor Steven Powis, NHS England’s national medical director, said: “These new drugs have an important role to play.
“If you test positive and are at high risk then we will contact you and if eligible, you will be able to access these new treatments.”
The Ministry of Health and Social Care is thought to have ordered 100,000 doses of the drug.
But estimates suggest more than 1.2 million Britons are eligible for treatment.
Sotrovimab is the second antibody treatment recommended for use in the UK after Ronapreve.
As well as these treatments, patients may also be offered molnupiravir is an anti-viral pill.
Last month, US drug companies Merck and Ridgeback Biotherapeutics unveiled their antiviral drug molnupiravir. reduced the incidence of severe Covid by 50% in one study.
The study results from drug trials on 775 people who recently tested positive for the virus but were not seriously ill.
They found that 7.3% of those given molnupiravir ended up in hospital, compared with 14.1% of those not given the drug.
https://www.the-sun.com/health/4307593/new-covid-drug-vulnerable-nhs-today/ New Covid drug that will help vulnerable patients is available on NHS TODAY